Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis

IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas

(2017) Amélie Darlix et al.   JOURNAL OF NEURO-ONCOLOGY

The utility of diffusion MRI with quantitative ADC measurements for differentiating high-grade from low-grade cerebral gliomas: Evidence from a meta-analysis

(2017) Li Zhang et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Adult IDH wild-type lower-grade gliomas should be further stratified

(2017) Abudumijit Aibaidula et al.   NEURO-ONCOLOGY

Apparent diffusion coefficient measurement in glioma: Influence of region-of-interest determination methods on apparent diffusion coefficient values, interobserver variability, time efficiency, and diagnostic ability

(2016) Xu Han et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

In vivo molecular profiling of human glioma using diffusion kurtosis imaging

(2016) Johann-Martin Hempel et al.   JOURNAL OF NEURO-ONCOLOGY

MR Imaging–Based Analysis of Glioblastoma Multiforme: Estimation ofIDH1Mutation Status

(2015) K. Yamashita et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours

(2015) Ji Xiong et al.   EUROPEAN RADIOLOGY

MRI findings and pathological features in early-stage glioblastoma

(2015) Makoto Ideguchi et al.   JOURNAL OF NEURO-ONCOLOGY

Neurosurgical management of adult diffuse low grade gliomas in Canada: a multi-center survey

(2015) Osaama H. Khan et al.   JOURNAL OF NEURO-ONCOLOGY

Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival

(2015) Valeria Cuccarini et al.   JOURNAL OF NEURO-ONCOLOGY

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

(2015) Jeanette E. Eckel-Passow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma

(2015) Philipp Kickingereder et al.   Scientific Reports

Diffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs. Whole Tumor Regions of Interest

(2015) Otso Arponent et al.   PLoS One

ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma

(2014) David E. Reuss et al.   ACTA NEUROPATHOLOGICA

Comparison of Multiple Parameters Obtained on 3T Pulsed Arterial Spin-Labeling, Diffusion Tensor Imaging, and MRS and the Ki-67 Labeling Index in Evaluating Glioma Grading

(2014) H. Fudaba et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Meta-Analysis of Diffusion Metrics for the Prediction of Tumor Grade in Gliomas

(2014) V.Z. Miloushev et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Can Diffusion Tensor Imaging Noninvasively Detect IDH1 Gene Mutations in Astrogliomas? A Retrospective Study of 112 Cases

(2014) W. L. Tan et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

(2014) David N. Louis et al.   BRAIN PATHOLOGY

Lower apparent diffusion coefficients indicate distinct prognosis in low-grade and high-grade glioma

(2014) Yong Cui et al.   JOURNAL OF NEURO-ONCOLOGY

Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging

(2014) Seunghyun Lee et al.   JOURNAL OF NEURO-ONCOLOGY

Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas

(2014) Elena Karavaeva et al.   MOLECULAR IMAGING AND BIOLOGY

How Molecular Testing Can Help (and Hurt) in the Workup of Gliomas

(2013) Kenneth Clark et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

ADC Values and Prognosis of Malignant Astrocytomas: Does Lower ADC Predict a Worse Prognosis Independent of Grade of Tumor?—A Meta-Analysis

(2013) Maria Zulfiqar et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate

(2013) Ovidiu C. Andronesi et al.   JOURNAL OF CLINICAL INVESTIGATION

Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults

(2011) Adriana Olar et al.   Annals of Diagnostic Pathology

MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas

(2011) I. S. Khayal et al.   NEURO-ONCOLOGY

FSL

(2011) Mark Jenkinson et al.   NEUROIMAGE

Management of Patients With Low-Grade Gliomas – A Survey Among German Neurosurgical Departments

(2011) M. Seiz et al.   Central European neurosurgery

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

(2010) Christian Hartmann et al.   ACTA NEUROPATHOLOGICA

Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis

(2010) Philippe Metellus et al.   ACTA NEUROPATHOLOGICA

Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity

(2010) Benjamin M. Ellingson et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Higher pAkt Expression Predicts a Significant Worse Prognosis in Glioblastomas

(2010) Yoshiyuki SUZUKI et al.   JOURNAL OF RADIATION RESEARCH

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

(2009) Lenny Dang et al.   NATURE

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapy

(2008) Daniel M Patterson et al.   Nature clinical practice. Oncology